Genmab A/S (GMAB)
30.06
-0.54
(-1.76%)
USD |
NASDAQ |
Feb 11, 16:00
30.06
0.00 (0.00%)
After-Hours: 20:00
Genmab EPS Diluted (Quarterly) : 0.6431 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 1.024 |
| Krystal Biotech, Inc. | 2.660 |
| Novo Nordisk A/S | 0.9419 |
| Ascendis Pharma A/S | -1.173 |
| Zealand Pharma A/S | -0.9003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 399.18M |
| Revenue (Quarterly) | 1.017B |
| Total Expenses (Quarterly) | 618.19M |
| Enterprise Value | 15.22B |
| Gross Profit Margin (Quarterly) | 94.32% |
| Profit Margin (Quarterly) | 39.24% |
| Earnings Yield | 7.83% |
| Operating Earnings Yield | 7.00% |
| Normalized Earnings Yield | 7.873 |